Your browser doesn't support javascript.
loading
Are novel glucose-lowering agents' cardiorenal benefits generalizable to individuals of Black race? A meta-trial sequential analysis to address disparities in cardiovascular and renal outcome trials enrolment.
Tang, Huilin; Kimmel, Stephen E; Hernandez, Inmaculada; Brooks, Maria M; Cusi, Kenneth; Smith, Steven M; Shi, Weilong; Winterstein, Almut G; Magnani, Jared W; Guo, Jingchuan.
Afiliação
  • Tang H; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Kimmel SE; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Hernandez I; Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.
  • Brooks MM; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Cusi K; Division of Endocrinology, Diabetes, and Metabolism, University of Florida, Gainesville, Florida, USA.
  • Smith SM; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Shi W; Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.
  • Winterstein AG; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Magnani JW; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Guo J; Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, Florida, USA.
Diabetes Obes Metab ; 24(1): 154-159, 2022 01.
Article em En | MEDLINE | ID: mdl-34472689
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Sistema Cardiovascular / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Sistema Cardiovascular / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido